Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention (Q24803327)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

17 June 2019

Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

breast neoplasm

1 reference

17 June 2019

1 reference

based on heuristic

inferred from title

genetic variation

1 reference

based on heuristic

inferred from title

Brian E. Henderson

2

object named as

B E Henderson

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Heather Spencer Feigelson

1

object named as

H S Feigelson

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

language of work or name

0 references

publication date

24 May 2000

4 references

Europe PubMed Central

PubMed publication ID

6 July 2017

13 March 2019

3 April 2019

17 June 2019

Breast Cancer Research

4 references

Europe PubMed Central

PubMed publication ID

6 July 2017

13 March 2019

3 April 2019

17 June 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

277-282

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

CYP17 genotype and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

7 April 2017

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

7 April 2017

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

7 April 2017

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

7 April 2017

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1186/BCR69

22 April 2017

A systematic review of genetic polymorphisms and breast cancer risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

Tissue-specific, cyclic adenosine 3',5'-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

Genetic susceptibility to cancer from exogenous and endogenous exposures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 September 2017

Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

30 May 2018

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

30 May 2018

Is tamoxifen effective in prevention of breast cancer?

1 reference

https://api.crossref.org/works/10.1186%2FBCR69

21 January 2018

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138788

28 November 2018

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

https://api.crossref.org/works/10.1186%2FBCR69

21 January 2018

Association between CYP17 polymorphisms and the development of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A polymorphism in the CYP17 gene increases the risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11250721

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24803327&oldid=2175273916"